Hannah Lee practices high stakes patent litigation in federal courts throughout the country. Over the past 12 years, she has served as trial counsel for her clients in nine multi-patent cases before district courts, the Patent Trial & Appeal Board and the International Trade Commission. Her practice focuses on innovative technologies in
the areas of computer security and pharmaceutical formulations.
Hannah is known for her ability to quickly grasp complicated technologies across different fields of study and present persuasive arguments to judges and juries in briefs and oral argument.
Among her most notable recognitions, she represented a specialty pharmaceutical company in district court litigation and served as lead counsel before the Patent Trial and Appeal Board in inter partes review proceedings where she obtained a complete victory for her client adverse to the petitioner Purdue Pharma LP, resulting in a $62 million settlement in a patent litigation involving OxyContin. In 2019, her advocacy for a biotechnology client resulted in a judgment of noninfringement and dismissal of a patent lawsuit filed in the Southern District of New York involving protein expression technology and age-related macular degeneration treatment. Recently, in May 2020, Hannah represented Centripetal Networks Inc., a start-up computer security company, in the first federal multi-patent bench trial conducted by videoconference on Zoom during the COVID-19 pandemic.
Hannah enjoys participating in bar association events that celebrate diversity, promote women and encourage participation in pro bono matters. She is a 2007 graduate of Northwestern University School of Law and obtained a Bachelor of Science in chemical engineering from Stanford University in 2003.
Last updated July 2020